scholarly journals P344 Short and medium term efficacy of adalimumab in ulcerative colitis – a multicentre, prospective observational study

2014 ◽  
Vol 8 ◽  
pp. S208
Author(s):  
Z. Szepes ◽  
A. Bálint ◽  
M. Szücs ◽  
F. Nagy ◽  
K. Farkas ◽  
...  
Epilepsia ◽  
2019 ◽  
Vol 60 (11) ◽  
pp. 2255-2262 ◽  
Author(s):  
Anna Rosati ◽  
Alessandra Boncristiano ◽  
Viola Doccini ◽  
Alessandra Pugi ◽  
Tiziana Pisano ◽  
...  

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Pietro Gianella ◽  
Elia Rigamonti ◽  
Marco Marando ◽  
Adriana Tamburello ◽  
Lorenzo Grazioli Gauthier ◽  
...  

Abstract Background All over the world, SARS-CoV-2 pneumonia is causing a significant short-term morbidity and mortality, but the medium-term impact on lung function and quality of life of affected patients are still unknown. Methods In this prospective observational study, 39 patients with SARS-CoV-2 pneumonia were recruited from a single COVID-19 hospital in Southern Switzerland. At three months patients underwent radiological and functional follow-up through CT scan, lung function tests, and 6 min walking test. Furthermore, quality of life was assessed through self-reported questionnaires. Results Among 39 patients with SARS-CoV-2 pneumonia, 32 (82% of all participants) presented abnormalities in CT scan and 25 (64.1%) had lung function tests impairment at three months. Moreover, 31 patients (79.5%) reported a perception of poor health due to respiratory symptoms and all 39 patients showed an overall decreased quality of life. Conclusions Medium-term follow up at three months of patients diagnosed with SARS-CoV-2 pneumonia shows the persistence of abnormalities in CT scans, a significant functional impairment assessed by lung function tests and a decreased quality of life in affected patients. Further studies evaluating the long-term impact are warranted to guarantee an appropriate follow-up to patients recovering from SARS-CoV-2 pneumonia.


Sign in / Sign up

Export Citation Format

Share Document